Scholarly Index
Darren R. Feldman
Memorial Sloan Kettering Cancer Center; 15,604 total citations; 389 total publications; best world rank #7
Memorial Sloan Kettering Cancer Center
15,604Total citations
389Total publications
53H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Testicular diseases and treatments | Lifetime | 97 | US 42 | 98.64 |
| Renal cell carcinoma treatment | Lifetime | 376 | US 213 | 98.31 |
| Neuroblastoma Research and Treatments | Lifetime | 485 | US 237 | 97.48 |
| Renal and related cancers | Lifetime | 602 | US 304 | 97.30 |
| Sarcoma Diagnosis and Treatment | Lifetime | 782 | US 379 | 97.38 |
| Ovarian cancer diagnosis and treatment | Lifetime | 845 | US 382 | 96.92 |
| Multiple Myeloma Research and Treatments | Lifetime | 838 | US 372 | 96.07 |
| Urologic and reproductive health conditions | Lifetime | 582 | US 284 | 96.49 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 741 | US 172 | 81.49 |
| Testicular diseases and treatments | 2021-2025 | 7 | US 4 | 98.57 |
| Renal cell carcinoma treatment | 2021-2025 | 202 | US 81 | 96.67 |
| Renal and related cancers | 2021-2025 | 288 | US 119 | 91.60 |
| Neuroblastoma Research and Treatments | 2021-2025 | 482 | US 180 | 88.61 |
| Urologic and reproductive health conditions | 2021-2025 | 549 | US 124 | 80.26 |
| Ear and Head Tumors | 2021-2025 | 579 | US 169 | 70.99 |
| Enzyme function and inhibition | 2021-2025 | 504 | US 26 | 54.49 |